Essen-Haus

Essen BioScience is a leading provider of analytical tools and software for live-cell imaging and analysis, primarily serving the global drug discovery and life science research markets. The company is best known for its flagship IncuCyte platform, which enables researchers to monitor and quantify cellular behavior in real-time over days or weeks within a standard laboratory incubator. This technology provides kinetic, image-based measurements that offer deeper biological insights compared to traditional endpoint assays. Following its acquisition by Sartorius in 2017, Essen BioScience has continued to expand its portfolio of reagents, software, and hardware to support applications in oncology, immunology, and neuroscience.